アレルギー性鼻炎を伴う小児上顎洞炎の治療 -抗アレルギー剤, クラリスロマイシン, カルボシステイン療法-

DOI 被引用文献1件 参考文献20件

書誌事項

タイトル別名
  • TREATMENT OF MAXILLARY SINUSITIS IN CHILDREN WITH NASAL ALLERGY

この論文をさがす

抄録

The clinical effects of Clarithromycin (CAM), S-carboxymethylcysteine (S-CMC) and anti-allergy agents were investigated in children with maxillary sinusitis and nasal allergies. The subjects were 95 children, 14 years or younger. The maxillary sinusitis was diagnosed by X-ray examinations. The pataients were classified into two treatment groups. Patients in group A received both 5-7mg/kg per day of CAM and 30mg/kg per day of S-CMC for 12 weeks, and those in group B received only 30mg/kg per day of S-CMC for 12 weeks. All patients in the study were also treated with anti-allergy agents. Moreover, the nasal treatment were given once a week locally.<br>On the fourth month after beginning treatment, X-ray examinations of the maxillary sinus showed 63.9% and 62.7% of cure rates in group A and B, respectively. There was no significant difference in cure rates between group A and B. These results suggest that the efficacy of treatment of maxillary sinusitis in children with nasal allergy is related to a regimen of S-CMC and anti-allergy agents and that CAM provides no added benefit to S-CMC and anti-allergy agents. The study also found an age-related decline in cure rates in goup A. This suggests that there may be pathological changes in their sinusitis as patients grow older.

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (20)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ